Factors Affecting Migration to GRCh38 in Laboratories Performing Clinical Next-Generation Sequencing

The most recent build of the human reference genome, GRCh38, was released in 2013. However, many laboratories performing next-generation sequencing (NGS) continue to align to GRCh37. Our aim was to assess the number of clinical diagnostic laboratories that have migrated to GRCh38 and discern factors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of molecular diagnostics : JMD 2021-05, Vol.23 (5), p.651-657
Hauptverfasser: Lansdon, Lisa A., Cadieux-Dion, Maxime, Yoo, Byunggil, Miller, Neil, Cohen, Ana S.A., Zellmer, Lee, Zhang, Lei, Farrow, Emily G., Thiffault, Isabelle, Repnikova, Elena A., Cooley, Linda D., Alaimo, Joseph T., Porath, Binu, Herriges, John C., Saunders, Carol J., Farooqi, Midhat S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The most recent build of the human reference genome, GRCh38, was released in 2013. However, many laboratories performing next-generation sequencing (NGS) continue to align to GRCh37. Our aim was to assess the number of clinical diagnostic laboratories that have migrated to GRCh38 and discern factors impeding migration for those still using GRCh37. A brief, five-question survey was electronically administered to 71 clinical laboratories offering constitutional NGS-based testing and analyzed categorically. Twenty-eight responses meeting inclusion criteria were collected from 24 academic and four commercial diagnostic laboratories. Most of these (14; 50%) reported volumes of
ISSN:1525-1578
1943-7811
DOI:10.1016/j.jmoldx.2021.02.003